BDTX
Black Diamond Therapeutics Inc
1.80$
-1.1%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -100.0% | – | – | – | +13,465.9% | -100.0% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | +31.5% | +40.0% | +28.4% | +0.9% | +0.2% | -0.7% | +0.0% | +0.6% | +0.0% | +1.4% | -89.6% | +0.0% | +0.0% | +0.0% | – | – | – | – | – | -59.1% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +27,031.8% | -100.1% | – | – | – | – | – | |
| – | +0.0% | +11.0% | +45.9% | +26.6% | +87.4% | -0.2% | +32.4% | -1.4% | +38.3% | +27.1% | +37.3% | +28.5% | +17.1% | +3.4% | -28.8% | -9.6% | -8.9% | -2.1% | -7.8% | +1.0% | -10.8% | +22.8% | -5.4% | -12.0% | -7.3% | +3.6% | -4.8% | -14.6% | -11.3% | -20.2% | -15.3% | +11.2% | +5.6% | – | |
| – | +0.0% | +144.6% | -5.8% | +24.1% | +63.4% | +85.8% | +14.7% | +91.6% | -12.1% | +14.3% | -2.2% | +45.4% | +1.3% | -3.2% | -17.1% | +23.0% | -11.6% | -10.0% | +15.4% | -6.0% | +1.0% | +14.2% | -29.2% | +20.4% | +42.9% | -45.5% | +14.6% | -17.0% | -17.4% | -13.7% | +12.0% | +7.3% | +9.6% | – | |
| – | +0.0% | +34.6% | +29.1% | +26.1% | +82.2% | +16.4% | +27.0% | +24.5% | +16.7% | +23.0% | +25.4% | +32.5% | +13.0% | +1.9% | -26.3% | -1.5% | -9.8% | -4.5% | -1.2% | -1.3% | -7.1% | +19.9% | -13.1% | -3.3% | +9.3% | -17.8% | +0.8% | -15.3% | -13.8% | -17.7% | +60.4% | -36.1% | +7.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -124.6% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | -99.9% | +116,100.0% | -99.8% | +57,500.0% | -17.7% | -18.1% | +16,096.3% | -99.7% | -4.9% | +45.6% | +140.9% | -49.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -118.7% | – | – | – | – | – | |
| – | – | – | – | – | – | -266.7% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -96.8% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -118.7% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -118.5% | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.